Structural Biomarker Analysis for Brain and Blood Cancer using Bioinformatics Methods |
||||
|
|
||||
|
||||
BibTeX: |
||||
|
@article{IJIRSTV4I2051, |
||||
Abstract: |
||||
|
We have identified the following biomarkers (protein and targets) for brain & blood cancer: DNA topoisomearase, Epidermal growth factor, Estrogen receptor, Adenosine deamenase, Receptor protein tyrosine kinase, Arachidonate 5-lipoxygenase and B-Raf proto-oncogenase\threonine- protein kinase. Biomarkers have considerable impact on the care of patients and are urgently needed for advancing diagnostics, prognostics and treatment of disease. This survey article highlights emerging bioinformatics methods for biomarker discovery in clinical metabolomics. This demonstrates that clinical bioinformatics has evolved into an essential element of biomarker discovery, translating new innovations and successes in profiling technologies and bioinformatics to clinical application. |
||||
Keywords: |
||||
|
Adenosine deamenase, Arachidonate 5-lipoxygenase, Biomarker, B-Raf proto-oncogenase\threonine- protein kinase, ,DNA topoisomearase ,Epidermal growth factor, Estrogen receptor, Receptor protein tyrosine kinase |
||||



